Related Experiment Video
Updated: Apr 18, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Innovative techniques in atrial fibrillation therapy].
1Abteilung für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland, a.metzner@asklepios.com.
Pulmonary vein isolation (PVI) for atrial fibrillation (AF) faces challenges. New catheter technologies and ablation strategies, including cryoenergy and laser, show promise for effective PVI and AF management.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Context:
- Atrial fibrillation (AF) management relies heavily on pulmonary vein isolation (PVI).
- Current radiofrequency ablation methods struggle to achieve consistent, durable lesions for PVI.
- Advancements are needed to improve the safety and efficacy of PVI procedures.
Purpose:
- To review innovative technologies and strategies for pulmonary vein isolation (PVI) in atrial fibrillation (AF) treatment.
- To evaluate the potential of novel ablation catheters and energy sources for PVI.
- To discuss emerging ablation strategies targeting AF drivers and autonomic influences.
Summary:
- Pulmonary vein isolation (PVI) is crucial for atrial fibrillation (AF) treatment, but achieving transmural lesions with radiofrequency ablation remains challenging.
- Innovative spiral and balloon-based catheters using cryoenergy and laser have demonstrated safe and effective PVI potential.
- New strategies involving AF-inducing foci ablation and ganglionic plexi modulation are under investigation for improved AF control.
Impact:
- Novel catheter designs and energy sources offer improved PVI efficacy and patient outcomes in AF treatment.
- Emerging ablation strategies may provide more targeted and effective solutions for complex atrial fibrillation cases.
- Further clinical evaluation of these advanced PVI techniques is essential for widespread adoption and improved AF management.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Venous Thrombosis III: Interprofessional Care
Heart Failure VI: Adjunct Therapies

